Trial Profile
A retrospective chart review of bevacizumab in patients with recurrent glioblastoma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 06 Nov 2015 New trial record